All Clinical Trials in United Kingdom

A listing of 3097 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

United Kingdom

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

NCT03547973

Recruiting

The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: The University of Arizona Cancer Center-North Campus, Tucson, Arizona +134 locations

The University of Arizona Cancer Center-North Campus, Tucson, Arizona

USC/Norris Comprehensive Cancer Center, Los Angeles, California

University of California San Francisco, San Francisco, California

Rocky Mountain Cancer Centers, Littleton, Colorado

Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut

Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Woodlands Medical Specialists, PA, Pensacola, Florida

Moffitt Cancer Center, Tampa, Florida

Winship Cancer Institute, Emory University, Atlanta, Georgia

University of Illinois Cancer Center, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

Southern Illinois University School of Medicine, Simmons Cancer Institute, Springfield, Illinois

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

Norton Cancer Institute, Downtown, Louisville, Kentucky

Maryland Oncology Hematology, P.A., Brandywine, Maryland

University of Michigan, Ann Arbor, Michigan

Karmanos Cancer Institute, Detroit, Michigan

Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska

Precision Cancer Research / New Mexico Oncology & Hematology Consultants, Albuquerque, New Mexico

Roswell Park Cancer Institute, Buffalo, New York

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York

Drug Shipping Address: New York-Presbyterian Hospital, New York, New York

Stony Brook Cancer Center, Stony Brook, New York

St. Luke's Hosptial - Bethlehem Campus, Easton, Pennsylvania

Medical University of Southern Carolina, Charleston, South Carolina

Thompson Oncology Group - Knoxville West, Knoxville, Tennessee

Henry-Joyce Cancer Clinic, Nashville, Tennessee

Houston Methodist Hospital, Houston Methodist Cancer Center, Houston, Texas

Mays Cancer Center, San Antonio, Texas

Renovatio Clinical, The Woodlands, Texas

University of Utah - Huntsman Cancer Hospital (IP Shipping Address), Salt Lake City, Utah

University of Virginia Cancer Center, Charlottesville, Virginia

Virginia Oncology Associates, Hampton, Virginia

Oncology Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Roanoke, Virginia

Seattle Cancer Care Alliance, Seattle, Washington

University of Wisconsin Clinical Science Center, Madison, Wisconsin

Centre Hospitalier Regional Universitaire (CHRU) de Besancon, Hopital Jean Minjoz, Besançon, Not set

Hopital Saint Andre (CHU de Bordeaux), Bordeaux, Not set

Centre Hospitalier Regional Universitaire Brest, Brest, Not set

Centre Jean Perrin, Clermont Ferrand Cedex, Not set

Centre Hospitalier Departmental (CHD) Vendee, La Roche sur Yon, Not set

Centre Oscar Lambret, Lille, Not set

Centre Leon Berard, Lyon Cedex 08, Not set

Institut Paoli Calmettes, Marseille CEDEX 9, Not set

Centre Antoine Lacassagne, Nice, Not set

Centre Hospitalier Universitaire De Nimes - Hopital Universitaire Caremeau, Nîmes cedex, Not set

Hopital European Georges-Pompidou (HEGP), Paris Cedex 15, Not set

Groupement Hospitalier Pitie-Salpetriere, Paris, Not set

Hopital Cochin, Paris, Not set

Centre Eugene Marquis, Rennes Cedex, Not set

Centre Hospitalier Prive Saint-Gregoire, Rennes, Not set

CHU de Rouen, Rouen, Not set

Hospitaux Universitaires de Strasbourg - Hopital Civil, Strasbourg, Not set

Hospital Foch, Suresnes, Not set

Institut Claudius Regaud, Toulouse Cedex 9, Not set

Institut de Cancerologie de Lorraine, Vandoeuvre les Nancy, Not set

Institut Gustave Roussy, Villejuif, Not set

Urologicum Duisburg, Duisburg, Not set

Centrum fur Hamatologie und Onkologie Bethanien, Frankfurt, Not set

Universitätsklinikum Frankfurt, Klinik für Urologie, Frankfurt, Not set

Universitatsklinikum Freiburg, Freiburg, Not set

Universitatsklinikum Hamburg-Eppendorf, Hamburg, Not set

University Hospital Heidelberg, Heidelberg, Not set

Marien Hospital Herne, Herne, Not set

Universitatsklinikum Jena, Jena, Not set

Institut für Versorgungsforschung in der Onkologie, Koblenz, Not set

Universitätsklinikum Magdeburg, Magdeburg, Not set

Universitätsklinikum Carl Gustav Carus an der TU Dresden, Mainz, Not set

Klinikum rechts der Isar der Technischen Universität München, Urologische Klinik und Poloklinik, München, Not set

Universitatsklinikum Munster, Klinik fur Urologie und Kinderurologie, Münster, Not set

Universitat Regensburg, Regensburg, Not set

Universitatsklinikum Tubingen, Klinik fur Urologie, Tübingen, Not set

Henry Dunant Hospital Center, 4th Oncology Department, Athens, Not set

University General Hospital of Ioannina, Oncology Department, Ioannina, Not set

Athens Medical Center, Oncology Department, Marousi, Not set

General Hospital of Patras Agios Andreas, Patra, Not set

Anassa General Clinic, Oncology-Chemotherapy Department, Volos, Not set

Ospedale San Donato, Arezzo, Not set

Centro di Riferimento Oncologico IRCCS, Aviano, Not set

ASST Cremona, Cremona, Not set

Ospedale Policlinico San Martino IRCCS, Genoa, Not set

Istituto Romagnolo per Io Studio dei Tumori (IRST) "Dino Amadori", Meldola, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

IRCCS Ospedale San Raffaele, Milano, Not set

Azienda Ospedaliero Universitaria Maggiore della Carita, Novara, Not set

Istituto Oncologico Veneto IRCCS - Ospedale Busonera, Padova, Not set

Azienda Ospedaliero-Universitaria Pisana, Pisa, Not set

Instituto Nazionale Tumori Regina Elena - IFO, Roma, Not set

Azienda Ospedaliera Santa Maria di Temi, Terni, Not set

Centro Ricerche Cliniche di Verona srl, Verona, Not set

Kyungpook National University Chilgok Hospital, Daegu, Not set

Keimyung University Dongsan Hospital, Daegu, Not set

National Cancer Center, Goyang-si, Not set

Chonnam National University Hospital, Gwangju, Not set

Chonnam National University Hwasun Hospital, Hwasun, Not set

Korea University - Anam Hospital, Seongbuk-Gu, Not set

Seoul National University Hospital, Seoul, Not set

Yonsei University Health System, Severance Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

SMG-SNU Boramae Medical Center, Seoul, Not set

Asan Medical Center, Seoul, Not set

The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Not set

Yonsei University - Wonju Severance Christian Hospital, Wonju-si, Not set

Pusan National University Yangsan Hospital, Yangsan, Not set

Institut Catala d'Oncologia Badalona - Hospital Universitari Germans Trias i Pujol, Badalona, Not set

Hospital del Mar, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

CEIC Hospital Vall d'Hebron, Barcelona, Not set

Hospital Universitario Reina Sofia, Cordoba, Not set

Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas, Not set

MD Anderson Cancer Centre, Madrid, Not set

Hospital Universitario Ramon Y Cajal, Madrid, Not set

Hospital Universitario Clinico San Carlos, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Puera de Hierro Majadahonda, Majadahonda, Not set

Hospital Sant Joan de Deu, Manresa, Not set

Complejo Hospitalario de Ourense, Orense, Not set

Hospital Universitario Marques de Valdecilla, Santander, Not set

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Hospital Universitario Miguel Servet, Zaragoza, Not set

Ankara Sehir Hastanesi, Ankara, Not set

Dicle Universitesi Tip Fakultesi Hastanesi, Diyarbakir, Not set

Trakya Universitesi Saglik Arastirma ve Uygulama Merkezi, Edrine, Not set

Istanbul Universitesi Cerrahpasa Tip Fakultesi Hastanesi, Istanbul, Not set

Medipol Mega Universite Hastanesi, Istanbul, Not set

T.C. Saglik Bakanligi Goztepe Prof Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set

Izmir Medical Point Hastanesi, Medikal Onkoloji Departmant, Izmir, Not set

Baskent Universitesi Adana Dr.Turgut Noyan Uygulama ve Arastima Merkezi, Seyhan, Not set

University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set

Barts Health NHS Trust, London, Not set

East and North Hertfordshire NHS Trust, Northwood, Not set

The Royal Marsden NHS Foundation Trust, Surrey, Not set

Conditions: Metastatic Urothelial Cancer

Learn More ›

Improving Muslim Women's Uptake of Cancer Screening (IMCAN)

NCT06106165

Recruiting

The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland. The results of this trial will inform the development of a full-scale randomised-controlled trial. Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.

Gender:

FEMALE

Ages:

Between 25 years and 74 years

Trial Updated:

04/11/2025

Locations: University of Glasgow, Glasgow, Scotland +1 locations

Conditions: Breast Cancer, Bowel Cancer, Cervical Cancer

Learn More ›

Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD

NCT06629675

Recruiting

Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: NIHR Leicester Biomedical Research Centre - Respiratory, Leicester, Leicestershire +1 locations

Conditions: Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Lung Disease, Chronic Obstructive Airway Disease

Learn More ›

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

NCT06731374

Recruiting

Streptococcus pneumoniae (pneumococcus) is a bacterium that causes just under four million serious infections every year. It is normal for pneumococcus bacteria to live in the noses of healthy adults and children as part of the nasal microflora without causing harm. This is called "carriage". But the bacteria can still be passed on to other people. If they are at-risk, for example elderly, or very young, or have pre-existing health conditions, the pneumococcus bacteria can cause pneumonia, which can cause serious life-threatening illness. Pneumococcus bacteria are surrounded by a sugar capsule. But the capsule does not always have the same components. As a result, the bacteria are classified into more than 100 different types. To make them effective, the vaccines that are currently available contain the sugar capsules of the most common pneumococcal types that cause disease. One such vaccine - PCV13 - has been effective globally in protecting against pneumococcus disease. It works because it controls the "carriage" (how a person carries the bacteria in their nose) of 13 types of the bacteria. Vaccines giving protection against other types of the bacteria are also becoming available worldwide. PCV15 is similar to PCV13 and protects against two additional types of the bacteria so may offer more protection. This study, which lasts 2 months and is funded by Merck Sharp \& Dohme (MSD), aims to assess if using PCV15 can protect against "carriage". To do this, investigators will use a well-established method already used with more than 2,000 people safely in other research. This involves "challenging" volunteers by putting a small amount of the pneumococcus bacteria into their noses. In this study, before they are challenged, volunteers will either be vaccinated with the real PCV15 vaccine or a dummy ("placebo"). The Investigators will then be able to compare the two groups to find out who the vaccine protected and who it did not. After the study everyone who takes part and fit into certain criteria will be given antibiotics to clear the pneumococcus colonisation. They will also be regularly monitored during the study to ensure their safety. A very small number of volunteers will be asked to have a biopsy to collect tissue samples from inside their nose before and after being vaccinated with PCV15. This will help researchers to understand more about how the immune system responds to the vaccine. The information gain in this project will help the investigators to understand how exactly PCV15 vaccine protects people against pneumococcus. This means that this vaccine and future pneumococcal vaccines will be improved to protect many lives in future around the world. Read Less

Gender:

ALL

Ages:

Between 18 years and 50 years

Trial Updated:

04/11/2025

Locations: Liverpool Vaccine Group, Liverpool, North West +1 locations

Conditions: Pneumococcal Disease, Pneumococcal Carriage

Learn More ›

Personalized Responses to Dietary Composition Trial 3

NCT04735835

Recruiting

The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large v... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Zoe US Inc., Needham, Massachusetts +1 locations

Conditions: Diabetes, Heart Diseases, Diet Habit, Diet Modification, Healthy, Obesity, Metabolism, Microbial Colonization

Learn More ›

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

NCT05463263

Recruiting

The Phase 1 part of the study is a dose escalation of STP938 as monotherapy. The Phase 2 part of the study is cohort expansion of STP938 as a monotherapy in 5 different B and T cell lymphomas.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Colorado Blood Cancer Institute, Denver, Colorado +14 locations

Conditions: Lymphoma, B-Cell, Lymphoma, T-Cell

Learn More ›

Path Active Multicentre Randomised Controlled Trial (Previous Pilot: Path Active; Safety and Tolerability Study)

NCT06084052

Recruiting

Path Active™ comprises a pair of monitoring insoles which measure parameters associated with foot ulceration in diabetes: temperature and pressure. The insoles are linked via an app to the wearer's mobile phone and also to a clinical dashboard so that both wearer and clinician are alerted to early signs of skin damage on the foot so that immediate preventive action can be taken. The study is a multisite randomised controlled trial which will evaluate the effectiveness of Path Active™ in 60 peopl... Read More

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

04/11/2025

Locations: Royal Free Hospital, London, Not set

Conditions: Diabetic Foot

Learn More ›

Study of STP938 in Advanced Solid Tumours

NCT06297525

Recruiting

The Phase 1a part of the study is a dose escalation of STP938 as a monotherapy. The Phase 1b part of the study is a safety expansion cohort of STP938 as a monotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Comprehensive Hematology Oncology, LLC, Saint Petersburg, Florida +6 locations

Conditions: Solid Tumor

Learn More ›

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

NCT05489705

Recruiting

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructive hypertrophic cardiomyopathy (HCM) who are receiving mavacamten, receiving other treatment for obstructive HCM, or not receiving treatment for obstructive HCM due to intolerance or failure of prior treatment. United States Sub-Study: The purpose of this study is to evaluate the safety of mavacamt... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: Alaska Heart Institute, Anchorage, Alaska +97 locations

Alaska Heart Institute, Anchorage, Alaska

Pima Heart and Vascular, Tucson, Arizona

UAMS, Little Rock, Arkansas

UC San Diego School of Medicine, La Jolla, California

Keck School of Medicine of USC-Usc, Los Angeles, California

Stanford Health Care Hospital & Clinics, Palo Alto, California

University Of California San Francisco Medical Center, San Francisco, California

UC Denver, AMC, Aurora, Colorado

Hartford HealthCare, Hartford, Connecticut

MedStar Washington Hospital Center, Washington, District of Columbia

Uf Health Jacksonville, Jacksonville, Florida

University of Hawaii Cancer Center, Honolulu, Hawaii

University of Chicago Dept of Medicine, Chicago, Illinois

Indiana. University, Indianapolis, Indiana

Franciscan Physician Network-Indiana Heart Physicians, Indianapolis, Indiana

University of Iowa Hospitals & Clinics, Iowa City, Iowa

University Of Kansas Medical Center & Medical Pavilion, Kansas City, Kansas

University Of Maryland, Ihv, Baltimore, Maryland

MedStar Health Research Institute, Baltimore, Maryland

Harvard (Massachusetts General Hospital), Boston, Massachusetts

Harvard Medical School - Brigham and Women's Hospital (BWH), Boston, Massachusetts

Spectrum Health Medical Group, Grand Rapids, Michigan

Henry Ford Health System, West Bloomfield, Michigan

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Cardiology Associates Research, Llc, Tupelo, Mississippi

St. Luke's Mid-America Heart Institute, Kansas City, Missouri

Washington University, Saint Louis, Missouri

CHI Health Reseach Center, Omaha, Nebraska

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Bassett Medical Center, Cooperstown, New York

Northwell Health, Manhasset, New York

Mount Sinai West, New York, New York

Mount Sinai Hospital, New York, New York

Saint Francis Hospital, Roslyn, New York

WMCHealth Advanced Physician Services, Valhalla, New York

Focus Clinical Research, Charlotte, North Carolina

Duke University Health System, Durham, North Carolina

Christ Hospital Health Network, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

St. Luke's University Health Network, Bethlehem, Pennsylvania

Lancaster General Hospital, Lancaster, Pennsylvania

AHN Allegheny General Hospital, Pittsburgh, Pennsylvania

University Of Pittsburgh, Pittsburgh, Pennsylvania

Geisinger Health System, Wilkes-Barre, Pennsylvania

Prisma Health - Upstate, Greenville, South Carolina

Tristar Centennial Medical Ctr, Nashville, Tennessee

Saint Thomas Health, Nashville, Tennessee

North Texas Cardiology Center, Dallas, Texas

Baylor Scott & White Research Institute, Dallas, Texas

The Methodist Hospital, Methodist Cancer Cencer, Houston, Texas

BI Research Center, Houston, Texas

Baylor Scott & White The Heart Hospital Plano, Plano, Texas

Baylor Scott & White Medical Centre - Temple, Temple, Texas

The Rector and Visitors of the Univ of Virginia, Charlottesville, Virginia

VCU Medical Center, Richmond, Virginia

Carilion Clinic; Virginia Tech-Carilion School of Medicine, Roanoke, Virginia

Virginia Mason Medical Center, Seattle, Washington

WVU Hospitals, Morgantown, West Virginia

University Of Wisconsin - Madison, Madison, Wisconsin

Medical College of Wisconsin, Inc (PI Address), Milwaukee, Wisconsin

Local Institution - 0082, Braunau am Inn, Not set

Local Institution - 0087, Graz, Not set

Local Institution - 0088, Innsbruck, Not set

Local Institution - 0084, Klagenfurt am Worthersee, Not set

Local Institution - 0086, Linz, Not set

Local Institution - 0085, St. Pölten, Not set

Local Institution - 0083, Wien, Not set

Centre Hospitalier Haguenau, Haguenau, Bas Rhin

Local Institution - 0093, Saint-Herblain, Loire Atlantique

Local Institution - 0090, Lille, Nord

Local Institution - 0091, Amiens Cedex 1, Somme

Local Institution - 0094, Toulon, Var

Local Institution - 0089, Poitiers, Vienne

Local Institution - 0098, Aalen, Baden Wuerttemberg

Local Institution - 0101, Erlangen, Bayern

Local Institution - 0095, Bernau, Berlin

Local Institution - 0100, Muenster, Nordrhein Westfalen

Local Institution - 0099, Dresden, Sachsen

Local Institution - 0097, Leipzig, Sachsen

Local Institution - 0096, Berlin, Not set

Research & Cardiovascular Corp, Ponce, Not set

Local Institution - 0106, Oviedo, Asturias

Local Institution - 0109, Palma De Mallorca, Baleares

Local Institution - 0104, Majadahonda, Madrid

Local Institution - 0105, El Palmar, Murcia

Local Institution - 0107, Burgos, Not set

Local Institution - 0102, Madrid, Not set

Local Institution - 0108, Madrid, Not set

Local Institution - 0103, Malaga, Not set

Local Institution - 0113, London, Greater London

Local Institution - 0115, London, Greater London

Local Institution - 0112, Manchester, Greater Manchester

Local Institution - 0111, Liverpool, Merseyside

Local Institution - 0110, Birmingham, West Midlands

Local Institution - 0114, Leeds, West Yorkshire

Local Institution - 0116, Cardiff, Not set

Conditions: Obstructive Hypertrophic Cardiomyopathy

Learn More ›

Nutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial

NCT06923241

Recruiting

An experiment exploring the perceived effectiveness of Nutri-score food labels with calorie labelling compared to calorie labelling only on food choice and consumption in a real-world setting

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: University of Liverpool, Liverpool, Merseyside

Conditions: PME, Food Choice, Food Labelling

Learn More ›

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

Recruiting

This is a first-in-human (FIH), Phase 1 open-label, multicentre dose escalation study investigating AVA6000 monotherapy administered intravenously in patients with locally advanced (unresectable) or metastatic solid tumours that are likely to be FAP positive. The study consists of an initial Phase 1a dose escalation portion and a subsequent Phase 1b dose expansion portion upon completion of the dose escalation portion.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: Memorial Sloan Kettering Cancer Center, New York, New York +8 locations

Conditions: Breast Cancer, Soft Tissue Sarcoma, Salivary Gland Tumor, Urothelial Carcinoma, Ovarian Carcinoma

Learn More ›

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

NCT05489237

Recruiting

This is the first clinical trial of IDRX-42. The study is designed to evaluate the safety, tolerability, PK, and preliminary antitumor activity of IDRX-42 in adult participants with advanced (metastatic and/or surgically unresectable) GIST.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: University of Miami, Miami, Florida +30 locations

University of Miami, Miami, Florida

Dana-Farber Cancer Institute, Boston, Massachusetts

Memorial Sloan Kettering, New York, New York

Oregon Health & Science University (OHSU), Portland, Oregon

Temple University Health System (Temple Health) - Fox Chase Cancer Center (FCCC) - Main Campus, Philadelphia, Pennsylvania

The University of Texas - MD Anderson Cancer Center, Houston, Texas

Universitaire Ziekenhuizen (UZ) Leuven - Campus Gasthuisberg - Leuvens Kankerinstituut (Leuven Cancer Institute) (LKI), Leuven, Not set

Beijing Cancer Hospital, Beijing, Beijing Sheng

Sun-Yat-sen University - The Sixth Affliliated Hospital, Guangzhou, Guangdong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Sheng

Zhongshan Hospital, Fudan University, Shanghai, Shanghai Sheng

Bergonie unicancer- Nouvelle Aquitaine - L'Institut Bergonie, Bordeaux, Gironde

Centre de Lutte Contre le Cancer (CLLC) - Universite de Lyon -Centre Leon-Berard, Lyon, Rhone

Assistance Publique Hopitaux de Marseille - Hopital de La Timone, Marseille, Not set

Centre de Lutte Centre le Cancer (CLCC) - Gustave Roussy, Villejuif, Not set

HELIOS Kliniken GmbH - HELIOS Klinikum Berlin-Buch, Berlin, Not set

University Hospital Essen-West German Cancer Center, Essen, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

National Cancer Center Hospital East, Kashiwa, Chiba

Shonan Kamakura General Hospital, Kamakura, Kanagawa

Osaka University Hospital, Suita, Osaka

National Cancer Center Hospital, Tokyo, Not set

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-Do

Asan Medical Center, Seoul, Not set

Seoul National University Hospital (SNUH), Seoul, Not set

Severance Hospital (Yonsei University Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Netherlands Cancer Institute, Amsterdam, North Holland

Erasmus University Medical Center -Kanker Instituut, Rotterdam, South Holland

Vall d' Hebron Institute of Oncology (VHIO), Barcelona, Not set

Royal Marsden NHS Foundation Trust, London, Not set

Conditions: Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases, Metastatic Cancer

Learn More ›